PF-Atlas › Clinical Trials › NCT03803787
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Inhaled budesonide · Phase 2
Registry ID
NCT03803787
Phase
Phase 2
Status
Recruiting
Drug / intervention
Inhaled budesonide
Sponsor
Instituto Nacional de Cancerologia de Mexico
Start
2018-09-01
About this trial
Inhaled budesonide is evaluated in NCT03803787, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Instituto Nacional de Cancerologia de Mexico. Current status: Recruiting.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03803787 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.